Turnstone Biologics Corp. Annual Income Tax Expense (Benefit) in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Turnstone Biologics Corp. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2022 to 2023.
  • Turnstone Biologics Corp. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $2K.
  • Turnstone Biologics Corp. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$180K.
  • Turnstone Biologics Corp. annual Income Tax Expense (Benefit) for 2023 was -$286K, a 303% decline from 2022.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$286K -$427K -303% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 $141K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.